The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient.
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000209:etiology; D006084:Graft Rejection / Q000187:drug effects; D004854:Herpesvirus 4, Human / Q000472:pathogenicity; D006801:Humans; D007239:Infections / Q000209:etiology*; D016030:Kidney Transplantation; D011183:Postoperative Complications / Q000209:etiology*; D011241:Prednisone / Q000008:administration & dosage; D012306:Risk; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone